Context Therapeutics Inc. (CNTX)
NASDAQ: CNTX · Real-Time Price · USD
1.630
-0.020 (-1.21%)
Nov 20, 2024, 4:00 PM EST - Market closed
Context Therapeutics Market Cap
Context Therapeutics has a market cap or net worth of $122.25 million as of November 21, 2024. Its market cap has increased by 522.50% in one year.
Market Cap
122.25M
Enterprise Value
37.69M
1-Year Change
522.50%
Ranking
Category
Stock Price
$1.63
Market Cap Chart
Since the IPO on October 20, 2021, Context Therapeutics's market cap has increased from $51.03M to $122.25M, an increase of 139.57%. That is a compound annual growth rate of 32.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 123.75M | 585.90% |
| Dec 29, 2023 | 18.04M | 73.39% |
| Dec 30, 2022 | 10.41M | -75.50% |
| Dec 31, 2021 | 42.46M | -16.78% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cardiff Oncology | 131.93M |
| Avalo Therapeutics | 129.32M |
| Innate Pharma | 128.52M |
| Candel Therapeutics | 128.44M |
| Compugen | 128.04M |
| Ventyx Biosciences | 125.16M |
| Cibus | 124.48M |
| Zomedica | 124.45M |